This case highlights the potential diagnostic confusion between IBD and strongyloidiasis. It underscores the potentially fatal consequences of unrecognized chronic strongyloidiasis and supports systematic screening prior to immunosuppressive therapy in at-risk populations.
Trabelsi et al. (Wed,) studied this question.